Delivery Order SPE2DB24D1205-SPE2DB25FCQUF

Award Date 10/15/24
Potential Completion Date 11/5/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ZEPZELCA 4 MG VIALS. The fixed-price, firm-fixed-price contract has a ceiling value of $18,675.40 and an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg vials of the cancer drug ZEPZELCA, with a ceiling value of $9,025.76 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $9,025.76 to supply ZEPZELCA 4 MG VIALS. The order has a completion date of February 2, 2024 and was awarded on January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. No set-aside designation was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $9,025.76 Firm Fixed Price Delivery Order is for the supply of Zepzelca 4 mg vials, a prescription medication. The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This is a $25,203.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 7, 2025 and covers a range of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and other medical commodities. Amerisourcebergen holds a...
This is a $8,937.84 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, to support military treatment facilities and federal healthcare programs. The contract has an ultimate completion...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,339.68 firm fixed-price delivery order is for the supply of Zirabev 100 mg/4 ml vials. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $46,304.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through February 25, 2025 and does not have a set-aside designation, indicating open competition. The contract provides for the delivery of a broad range of pharmaceutical products and medical supplies, including specialty...
This $6,522.53 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 10, 2024. The order is for the supply of various pharmaceutical products and medical supplies to support the medical needs of federal agencies and military healthcare facilities. The contract has an ultimate completion date of September 11, 2024 and is not set aside for any specific business...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCQUF
    Delivery Order

This is a $9,025.76 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ZEPZELCA 4 MG VIALS medical products. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for providing a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies. These IDCs serve as primary vehicles for Amerisourcebergen to efficiently deliver essential pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings. This specific contract award is not designated as a set-aside.

Generated 1/14/25, 9:10 AM